Study: High-dose losartan doesn't raise death risk in heart patients

04/11/2012 | PhysiciansBriefing.com

A Danish study of more than 6,000 heart failure patients found that those who take a high dose of losartan have the same risk of dying as those taking a high dose of candesartan. The risk of death, however, is higher among heart failure patients who take low- or medium-dose losartan. The findings appear in the Journal of the American Medical Association.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN